TROUGH LEVELS OF INFLIXIMAB IN A COHORT OF PRIMARY NON-RESPONDERS

(1) Laboratory of Gastroenterology, University Hospitals Leuven

(2) Laboratory of Farmaceutical Biology, Catholic University of Leuven, Leuven, Belgium



This item was part of the Anti TNF therapy in IBD: Current to future session at Gastro 2009 UEGW/WCOG London (17th UEGW)

This item can be cited as: Gut 2009; 58 (Suppl II) A70